GGrantIndex
← Leaderboards

Jorge A Marrero

University Of Michigan At Ann Arbor

$3,014,574
Attributed
$7,074,609
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,074,609 · 6

By mechanism

U01$3,730,583 · 1
R01$2,524,195 · 1
K23$661,500 · 1
R03$150,480 · 1
M01$7,851 · 2

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Early Diagnosis

Research focus

Early DiagnosisMalignant Neoplasm Of LiverBiological MarkersMalignant NeoplasmsProspectivePrimary Carcinoma Of The Liver CellsCohortTumorCirrhosisDiagnosticEvaluationValidationAlpha-FetoproteinsImageDesignSamplingSerumDetectionAreaPerformanceBiomarker PanelBlindedEarly Detection BiomarkersBlood

Grant awards (18)

Clinical Validation Center for Hepatocellular Carcinoma$893,833
U01 · FY2025 · CA
Clinical Validation Center for Hepatocellular Carcinoma$1,007,940
U01 · FY2024 · CA
Clinical Validation Center for Hepatocellular Carcinoma$1,041,376
U01 · FY2023 · CA
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$405,980
R01 · FY2023 · CA
Clinical Validation Center for Hepatocellular Carcinoma$787,434
U01 · FY2022 · CA
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$521,077
R01 · FY2022 · CA
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$531,711
R01 · FY2021 · CA
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$518,911
R01 · FY2020 · CA
Translation of a biomarker panel for the early detection of hepatocellular carcinoma$546,516
R01 · FY2019 · CA
Complications of Cirrhosis in American Patients$132,300
K23 · FY2008 · DK · contact PI
Early Detection and Prognosis of Patients with Hepatocellular Carcinoma$74,480
R03 · FY2008 · DK · contact PI
Complications of Cirrhosis in American Patients$132,300
K23 · FY2007 · DK · contact PI
Early Detection and Prognosis of Patients with Hepatocellular Carcinoma$76,000
R03 · FY2007 · DK · contact PI
STUDY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLUL$227
M01 · FY2007 · RR · contact PI
Complications of Cirrhosis in American Patients$132,300
K23 · FY2006 · DK · contact PI
Complications of Cirrhosis in American Patients$132,300
K23 · FY2005 · DK
Complications of Cirrhosis in American Patients$132,300
K23 · FY2004 · DK
Treatment of Hepatocellular Carcinoma w/ Tetrathiomolybdate (UMCC 0040)$7,624
M01 · FY2004 · RR